Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy

Journal of Gastrointestinal Surgery

Volumn 16, Issue 7, 2012, Pages 1296-1302

  Shridhar, Ravi ^a   Hayman, Thomas ^b   Hoffe, Sarah E ^a   Weber, Jill ^a   Almhanna, Khaldoun ^a   Chuong, Michael ^a   Karl, Richard C ^a   Meredith, Kenneth L ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Body mass index; Esophageal adenocarcinoma; Esophagectomy; Neoadjuvant chemoradiotherapy

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; AGED; ARTICLE; BODY MASS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; EVALUATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OBESITY; POSTOPERATIVE COMPLICATION; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; BODY MASS INDEX; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; OBESITY; OVERWEIGHT; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84862493920     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-1843-4     Document Type: Article

References (30)

1. Cancer Statistics, in Clinical Cancer Advances 20092009, American Society of Clinical Oncology: Alexandria, VA.
2. Lambert, R. and P. Hainaut, Esophageal cancer: cases and causes (part I). Endoscopy, 2007. 39(6): p. 550-5.
3. Blot, W. J. and J. K. McLaughlin, The changing epidemiology of esophageal cancer. Semin Oncol, 1999. 26(5 Suppl 15): p. 2-8.
4. Brown, L. M., S. S. Devesa, and W. H. Chow, Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst, 2008. 100(16): p. 1184-7.
5. Renehan, A. G., et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008. 371(9612): p. 569-78.
6. Chak, A., et al., Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol, 2009. 104(8): p. 1913-21.
7. Carmichael, A. R., Obesity and prognosis of breast cancer. Obes Rev, 2006. 7(4): p. 333-40.
8. Chlebowski, R. T., E. Aiello, and A. McTiernan, Weight loss in breast cancer patient management. J Clin Oncol, 2002. 20(4): p. 1128-43.
9. Dignam, J. J., et al., Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst, 2006. 98(22): p. 1647-54.
10. Li, D., et al., Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA, 2009. 301(24): p. 2553-62.
11. Chow, W. H., et al., Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst, 1998. 90(2): p. 150-5.
12. El-Serag, H. B., et al., Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol, 2005. 100(10): p. 2151-6.
13. Lagergren, J., R. Bergstrom, and O. Nyren, Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med, 1999. 130(11): p. 883-90.
14. Shaheen, N. and D. F. Ransohoff, Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. Jama, 2002. 287(15): p. 1972-81.
15. Murray, L., et al., Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol, 2003. 32(4): p. 645-50.
16. Nilsson, M., et al., Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. Jama, 2003. 290(1): p. 66-72.
17. Calle, E. E., et al., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med, 2003. 348(17): p. 1625-38.
18. Enzinger, P. C. and R. J. Mayer, Esophageal cancer. N Engl J Med, 2003. 349(23): p. 2241-52.
19. Vaughan, T. L., et al., Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 1995. 4(2): p. 85-92.
20. Moon, H. G., et al., Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol, 2008. 15(7): p. 1918-22.
21. Stewart, S. T., D. M. Cutler, and A. B. Rosen, Forecasting the effects of obesity and smoking on U. S. life expectancy. N Engl J Med, 2009. 361(23): p. 2252-60.
22. Dindo, D., et al., Obesity in general elective surgery. Lancet, 2003. 361(9374): p. 2032-5.
23. Melis, M., et al., An elevated body mass index does not reduce survival after esophagectomy for cancer. Annals of surgical oncology, 2011. 18(3): p. 824-31.
24. Grotenhuis, B. A., et al., Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer. World J Surg, 2010.
25. Kilic, A., et al., Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg, 2009. 87(2): p. 412-5.
26. Healy, L. A., et al., Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg, 2007. 134(5): p. 1284-91.
27. Morgan, M. A., et al., Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus, 2007. 20(1): p. 29-35.
28. Rodriguez, C., et al., Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev, 2001. 10(4): p. 345-53.
29. Rodriguez, C., et al., Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. Am J Epidemiol, 2001. 153(2): p. 145-52.
30. McRackan, T. R., et al., Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope, 2008. 118(7): p. 1180-5.